Alphabet's Google Cloud unit is bracing for record online shopping during the holidays, leading to a fourth-quarter surge in sales from US retailers.
Carrie Tharp, vice president of retail and consumer at Google Cloud, said they're planning for "peak on top of peak" during holiday discount days such as Black Friday and Cyber Monday in November and December.
Google needs to ensure it has enough servers to withstand increased shopping for such stores as Best Buy Co., Kohls Corp., and Wayfair Inc.
Electronics retailer Best Buy Co. announced a multi-year deal with Google Cloud to centralize customer and product data towards improving its loyalty program and online ad campaigns.
Tharp said she hopes Google would eventually power Best Buy's web ordering system.
Tharp noted that some retailers are now adopting Google Cloud's predictive algorithms years ahead to help work out the most efficient way of fulfilling orders.
Google Cloud generated about 30 percent of its revenue during the fourth quarter of the last two years.


Standard Chartered Expands Hedge Fund Access for Wealth Clients
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
OpenAI Revenue Rises 18% in Q2 as Losses Widen and Anthropic Surges Ahead
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Google to Buy Spirit Airlines Business Data for $10 Million to Train AI
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Moody’s Affirms NVIDIA Aa1 Rating as AI Data Center Guarantees Reach $105 Billion
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Nordson Stock Rises as Q3 Earnings Beat Estimates, Outlook Raised
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
SK Hynix Shares Surge on Record $28.6 Billion Buyback
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback 



